Jean-Pierre Bizzari - 03 Jun 2025 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
Director
Signature
/s/ Lisa Kallebo, as Attorney-in-Fact for Jean-Pierre Bizzari
Issuer symbol
ADCT
Transactions as of
03 Jun 2025
Net transactions value
$0
Form type
4
Filing time
05 Jun 2025, 17:09:17 UTC
Previous filing
18 Jun 2024
Next filing
09 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BIZZARI JEAN-PIERRE Director 430 MOUNTAIN AVENUE, SUITE 404, NEW PROVIDENCE /s/ Lisa Kallebo, as Attorney-in-Fact for Jean-Pierre Bizzari 05 Jun 2025 0001630914

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares Award $0 +40,000 +50% $0.000000 119,502 03 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.